Skip to main content
. 2021 Jun 4;45(6):529–536. doi: 10.1093/jat/bkab064

Table II.

2021 Recommended Scope and Cutoffs for Tier I Drugs/Drug Classes (ng/mL) for Screening and Confirmation in Blood, Urine and Oral Fluid

Blood Urine Oral fluid
Drug Screen Confirm Screen Confirm Screen Confirm
DRE category; cannabinoids
9-THC 1 4 1
Carboxy-THC 10 5 20 5
11-hydroxy-THC 1
DRE category; CNS stimulants
Methamphetamine 20 20 200 50 20 20
Amphetamine 20 20 200 50 20 20
MDMAa 20 50 20 20
MDAa 20 50 20 20
Cocaine 10 20 15b 8
Benzoylecgonine 50 50 150 50 15b 8
Cocaethylene 10 20 8
DRE category; CNS depressants
Carisoprodol 1,000 1,000 1,000 1,000 500 500
Meprobamatea 500 500 500
Zolpidem 10 10 20 20 10 10
Low-dose benzodiazepines 10 50 5
Alprazolam 10 50 1
Alpha-hydroxyalprazolam 50
Clonazepam 10 50 1
7-Aminoclonazepam 10 50 1
Lorazepam 10 50 1
High-dose benzodiazepines 50 100 5
Diazepam 20 50 1
Nordiazepam 20 50 1
Oxazepam 20 50 1
Temazepam 20 50 1
DRE category; narcotic analgesics
Codeinea 10 50 30 5
6-Acetylmorphine 5 10 1
Buprenorphine 1 0.5 5 1 1 2
Norbuprenorphine 1 1
Fentanyl 1 0.5 1 1 1 0.5
Hydrocodonea 10 50 30 5
Hydromorphonea 5 50 30 5
Methadone 50 20 300 50 20 10
Morphine 10 10 200 50 30 5
Oxycodonea 10 10 100 50 30 5
Oxymorphonea 5 50 30 5
Tramadol 100 50 100 50 50 10
O-Desmethyltramadol 50 50
a

Must have ≥80% cross-reactivity if using immunoassay for blood and urine.

b

Screening for either benzoylecgonine or cocaine in oral fluid is acceptable.